Table 3.
Seroprevalence and GMT of nAb against different types of enteroviruses by gender and district
| Pathogen, seroprevalence % (GMT) | ||||||||
|---|---|---|---|---|---|---|---|---|
| EV-A71 | CV-A16 | CV-A6 | CV-A10 | CV-B3 | CV-B5 | ECHO25 | ECHO30 | |
| Gender | ||||||||
| Male (n = 255) | 34.5 (52.6) | 20.8 (47.4) | 36.1 (48.1) | 38.4 (43.1) | 31.4 (100.4) | 30.6 (58.0) | 13.7 (32.0) | 51.0 (78.0) |
| Female (n = 260) | 40.7 (37.2) | 28.8 (44.6) | 42.7 (47.4) | 46.9 (47.4) | 37.7 (97.1) | 33.8 (58.7) | 15.0 (33.2) | 25.7 (73.2) |
| District | ||||||||
| Siming (n = 83) | 26.5 (51.3) | 18.0 (33.5) | 20.1 (28.3) | 34.9 (43.7) | 25.3 (66.1) | 20.5 (48.1) | 7.2 (22.6) | 16.9 (45.3) |
| Huli (n = 95) | 47.4 (39.1) | 28.4 (45.8) | 34.7 (50.8) | 41.1 (41.0) | 30.5 (65.5) | 33.7 (55.0) | 7.4 (32.0) | 30.5 (105.7) |
| Haicang (n = 84) | 33.3 (34.5) | 29.8 (64.0) | 54.8 (54.2) | 42.7 (41.1) | 31.0 (112.0) | 35.7 (53.2) | 19.1 (51.4) | 29.8 (73.5) |
| Jimei (n = 82) | 41.5 (44.3) | 25.6 (49.1) | 47.6 (47.3) | 39.0 (52.7) | 30.5 (147.0) | 36.6 (51.2) | 18.3 (29.2) | 20.7 (104.4) |
| Xiang’an (n = 82) | 40.2 (45.7) | 29.3 (39.2) | 42.7 (55.7) | 57.3 (43.0) | 42.7 (135.8) | 32.9 (80.6) | 22.0 (34.6) | 24.4 (43.7) |
| Tong’an (n = 89) | 36.0 (51.5) | 18.1 (41.5) | 37.1 (42.0) | 41.6 (54.0) | 47.2 (89.0) | 33.7 (64.0) | 13.5 (22.6) | 28.1 (86.8) |
nAb neutralizing antibody; A neutralizing titer of ≥ 1:16 was used as a threshold for seropositive; n the number of seropositive samples, GMT geometric mean titer